WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2010025340) MARKERS AND METHODS FOR ASSESSING AND TREATING ULCERATIVE COLITIS AND RELATED DISORDERS USING A 20 GENE PANEL
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2010/025340    International Application No.:    PCT/US2009/055323
Publication Date: 04.03.2010 International Filing Date: 28.08.2009
IPC:
G01N 33/48 (2006.01)
Applicants: CENTOCOR ORTHO BIOTECH INC. [US/US]; 800/850 Ridgeview Drive Horsham, PA 19044 (US) (For All Designated States Except US).
LI, Xilin [US/US]; (US) (For US Only).
BARIBAUD, Frederic [CH/US]; (US) (For US Only)
Inventors: LI, Xilin; (US).
BARIBAUD, Frederic; (US)
Agent: JOHNSON, Philip, S.; Johnson & Johnson One Johnson & Johnson Plaza New Brunswick, NJ 08933 (US)
Priority Data:
61/092,966 29.08.2008 US
Title (EN) MARKERS AND METHODS FOR ASSESSING AND TREATING ULCERATIVE COLITIS AND RELATED DISORDERS USING A 20 GENE PANEL
(FR) MARQUEURS ET PROCÉDÉS POUR ÉVALUER ET POUR TRAITER UNE RECTO-COLITE HÉMORRAGIQUE ET DES TROUBLES ASSOCIÉS À L'AIDE D'UN ENSEMBLE DE 20 GÈNES
Abstract: front page image
(EN)A method for assessment of the suitability of a target therapy for a gastrointestinal-related disorder such as ulcerative colitis, in a subject evaluates the presence, absence, and/or magnitude of expression of one or more genes in a 20- or 5-member gene panel in a sample. The method enables identification of the effectiveness of target therapies prior to starting a patient on such therapies
(FR)L'invention concerne un procédé pour évaluer la pertinence d'une thérapie cible pour un trouble de type gastro-intestinal, notamment une recto-colite hémorragique, chez un patient. Ce procédé permet d'évaluer la présence, l'absence, et/ou l'amplitude d'expression d'un ou de plusieurs gènes appartenant à un ensemble de 20 ou 5 gènes contenu dans un échantillon. Ce procédé permet d'identifier l'efficacité de thérapies cibles avant qu'un patient commence à être traité par de telles thérapies.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)